新冠疫情对结直肠癌患者治疗的影响。
Impact of COVID-19 pandemic on treatment of colorectal cancer patients.
机构信息
Department of Colorectal Surgery, Digestive Disease and Surgery Institute, Cleveland Clinic, Cleveland, OH, USA.
Hematology and Medical Oncology, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH, USA.
出版信息
Am J Surg. 2023 May;225(5):934-936. doi: 10.1016/j.amjsurg.2023.01.028. Epub 2023 Jan 31.
BACKGROUND
Modifications to practice during COVID pandemic impacted health maintenance and treatment of cancer patients.
METHODS
We conducted a retrospective cohort study of all consecutive patients presenting to our institution with a new diagnosis of colorectal cancer pre-COVID (January 2017 to December 2019) and post-COVID (January to December 2020).
RESULTS
The total number of patients with a new diagnosis of CRC was 2196. The pre-COVID period had 1891 patients whereas post-COVID period had 305. The median number of patients diagnosed with CRC per month was 50 and 35.5 pre and post-COVID, respectively. Time to treatment initiation was similar with no difference in stage at presentation for the pre and post-COVID periods.
CONCLUSION
There was a significant decrease in colorectal cancer diagnosis number and rate (p < 0.01) during the COVID era with no difference in staging at diagnosis or time to treatment initiation.
背景
在 COVID 大流行期间，实践的改变影响了癌症患者的健康维持和治疗。
方法
我们对在我院新诊断为结直肠癌的所有连续患者进行了回顾性队列研究，这些患者在 COVID 之前（2017 年 1 月至 2019 年 12 月）和 COVID 之后（2020 年 1 月至 12 月）。
结果
新诊断为 CRC 的患者总数为 2196 例。COVID 前有 1891 例，COVID 后有 305 例。COVID 前和后每月诊断 CRC 的患者中位数分别为 50 例和 35.5 例。治疗开始的时间相似，COVID 前和后诊断时的分期没有差异。
结论
在 COVID 期间，结直肠癌的诊断数量和比率显著下降（p<0.01），但诊断分期或治疗开始时间没有差异。
Zotero 插件